A potent peptide affinity reagent for the opiate receptor.

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Enkephalins are endogenous opioid peptides that modulate pain and reward pathways.
• Developing selective and potent enkephalin analogues is crucial for understanding opioid receptor function.
• Alkylating agents can serve as valuable tools for probing receptor-ligand interactions.

Purpose of the Study:

• To synthesize and characterize a novel enkephalin analogue, Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone.
• To evaluate the biological potency and receptor interaction profile of this new compound.
• To investigate its potential as an irreversible inhibitor of enkephalin receptors.

Main Methods:

• Chemical synthesis of the enkephalin analogue Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone.
• Characterization of the synthesized compound using standard analytical techniques.
• Assessment of biological potency in various in vitro assays, including receptor binding and functional assays.
• Evaluation of irreversible inactivation of enkephalin receptors in rat brain membranes.
• Determination of inhibitory effects on electrically stimulated contractions in mouse vas deferens.

Main Results:

• Successful synthesis and characterization of the novel enkephalin analogue.
• The compound demonstrated very high biological potency across multiple assays.
• Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone functions as an alkylating affinity reagent.
• Irreversible inactivation of a specific population of enkephalin receptors was observed in rat brain preparations.
• Irreversible inhibition of electrically stimulated contractions in the mouse vas deferens was confirmed.

Conclusions:

• The novel enkephalin analogue, Tyr-D-Ala-Gly-Phe-Leu-chloromethyl ketone, is a potent and effective irreversible inhibitor.
• This compound serves as a valuable pharmacological tool for studying enkephalin receptor populations.
• Its ability to selectively and irreversibly target receptors opens avenues for further research into opioid signaling.